Education
About Us
Working with TipRanks
Follow Us
Ocular Therapeutix (OCUL)
NASDAQ:OCUL
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 51.82M | $ 63.72M | $ 58.44M | $ 51.49M | $ 43.52M |
| Gross Profit | $ 45.25M | $ 58.10M | $ 53.16M | $ 46.95M | $ 39.12M |
| Operating Income | $ -270.02M | $ -171.78M | $ -82.38M | $ -78.65M | $ -78.04M |
| EBITDA | $ -249.78M | $ -176.14M | $ -66.42M | $ -61.91M | $ 2.54M |
| Net Income | $ -265.94M | $ -193.51M | $ -80.74M | $ -71.04M | $ -6.55M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 737.06M | $ 392.10M | $ 195.81M | $ 102.30M | $ 164.16M |
| Total Assets | $ 808.06M | $ 457.94M | $ 252.06M | $ 149.29M | $ 204.89M |
| Total Debt | $ 79.78M | $ 75.78M | $ 83.39M | $ 64.28M | $ 58.98M |
| Net Debt | $ -657.28M | $ -316.32M | $ -112.42M | $ -38.02M | $ -105.18M |
| Total Liabilities | $ 153.75M | $ 142.59M | $ 160.93M | $ 113.91M | $ 116.89M |
| Stockholders' Equity | $ 654.31M | $ 315.34M | $ 91.13M | $ 35.38M | $ 88.00M |
| Cash Flow | |||||
| Free Cash Flow | $ -216.89M | $ -135.97M | $ -76.32M | $ -63.32M | $ -66.74M |
| Operating Cash Flow | $ -204.88M | $ -134.68M | $ -70.23M | $ -59.60M | $ -65.55M |
| Investing Cash Flow | $ -11.88M | $ -1.29M | $ -6.09M | $ -3.71M | $ -1.19M |
| Financing Cash Flow | $ 561.72M | $ 332.11M | $ 169.83M | $ 1.45M | $ 2.85M |